RxDoctor Payments Data

Paul Conrad, MD

Otolaryngology · Quincy, ILNPI 1528028214

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $4,250 of the $5,908 with a category attached, or 71.9%. 19 manufacturers reported payments, led by Aerin Medical Inc. at 34.8% of the total. Reporting peaked in 2023 at $2,103 and has fallen 51.4% since, to $1,023 in 2025.

$5,908in general payments, 2019–2025

Across 103 payments — averaging $57.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Aerin Medical Inc.$2K
  • Integra Lifesciences Corporation$1K
  • Inspire Medical Systems, Inc.$496
  • Sanofi$467
  • Stryker$418
  • Intersect ENT, Inc.$388
  • plus $1K from 13 others

What the payments were for

  • Travel & lodging$1,63428%
  • Food & beverage$4,25072%
  • Other$240%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,908 in reported general payments places this provider in the 85th percentile of 390 otolaryngology providers in Illinois.

See all otolaryngology providers in Illinois

Medicare billing

Part B allowed, 2024
$100,777
Medicare patients
234
Services billed
898

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent PenDupilumab12$43,234
Ipratropium Bromide130$3,105
Pilocarpine Hcl12$884
Cefdinir22$477
Mometasone Furoate13$291
Pantoprazole Sodium54$261
Fluticasone Propionate25$252
Amitriptyline Hcl19$243
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav26$205
Levofloxacin15$182
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip12$170
Triamcinolone Acetonide11$125
Ondansetron OdtOndansetron20$116
Methylprednisolone21$105
Dexamethasone11$105

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Quincy

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →